These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8605937)

  • 1. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli.
    Choi MS; Holmann M; Atkins CJ; Klaus GG
    Eur J Immunol; 1996 Mar; 26(3):676-82. PubMed ID: 8605937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
    Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C
    Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    Li L; Krajewski S; Reed JC; Choi YS
    Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
    Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins.
    Pittner BT; Snow EC
    Cell Immunol; 1998 May; 186(1):55-62. PubMed ID: 9637765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
    Lu L; Chaudhury P; Osmond DG
    J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
    J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-modulation of a novel Bax-associated protein during apoptosis in normal mature B lymphocytes.
    He H; Hershberger PA; McCarthy SA
    J Immunol; 1998 Aug; 161(3):1176-82. PubMed ID: 9686577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
    Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents.
    Schwarz YX; Yang My; Qin D; Wu J; Jarvis WD; Grant S; Burton GF; Szakal AK; Tew JG
    J Immunol; 1999 Dec; 163(12):6442-7. PubMed ID: 10586034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
    Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
    Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
    Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
    Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.
    Hasbold J; Johnson-Léger C; Atkins CJ; Clark EA; Klaus GG
    Eur J Immunol; 1994 Aug; 24(8):1835-42. PubMed ID: 7519998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.
    Broome HE; Dargan CM; Krajewski S; Reed JC
    J Immunol; 1995 Sep; 155(5):2311-7. PubMed ID: 7650367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
    Feng B; Cheng S; Hsia CY; King LB; Monroe JG; Liou HC
    Cell Immunol; 2004; 232(1-2):9-20. PubMed ID: 15922711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
    Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
    Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.